Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali

Trial Profile

Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali

Recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2019

At a glance

  • Drugs Malaria vaccine live attenuated-Sanaria (Primary) ; Artemether/lumefantrine
  • Indications Falciparum malaria
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Feb 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Feb 2019 to 25 Feb 2019.
    • 25 Jan 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 28 Jan 2019 to 1 feb 2019.
    • 17 Jan 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 2 Jan 2019 to 23 Jan 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top